|
| 6-(TRIFLUOROMETHYL)URACIL Basic information |
Product Name: | 6-(TRIFLUOROMETHYL)URACIL | Synonyms: | 6-(TRIFLUOROMETHYL)URACIL;6-(TRIFLUOROMETHYL)URACYL;6-(TRIFLUOROMETHYL)-2,4-(1H,3H)PYRIMIDINEDIONE;2,4(1H,3H)-Pyrimidinedione, 6-(trifluoromethyl)-;6-(Trifluoromethyl)-2,4-pyrimidinediol;6-Trifluoromethyl-1H-pyrimidine-2,4-dione;6-(Trifluoromethyl)pyrimidine-2,4(1H,3H)-dione;2,4-Dihydroxy-6-trifluoromethylpyrimidine | CAS: | 672-45-7 | MF: | C5H3F3N2O2 | MW: | 180.08 | EINECS: | 211-593-2 | Product Categories: | Pyrimidine series;Heterocyclic Compounds;Building Blocks;Heterocyclic Building Blocks;Pyrimidines | Mol File: | 672-45-7.mol | |
| 6-(TRIFLUOROMETHYL)URACIL Chemical Properties |
Hazard Codes | Xi | Safety Statements | 24/25 | WGK Germany | 3 | HazardClass | IRRITANT | HS Code | 29335990 |
| 6-(TRIFLUOROMETHYL)URACIL Usage And Synthesis |
Uses | 6-(Trifluoromethyl)-2,4(1H,3H)-pyrimidinedione is an anticancer drug, produced from catalytic trifluoromethylation of uracil. | Synthesis Reference(s) | The Journal of Organic Chemistry, 24, p. 113, 1959 DOI: 10.1021/jo01083a607 |
| 6-(TRIFLUOROMETHYL)URACIL Preparation Products And Raw materials |
|